Hermetica Superfood Encyclopedia
The Short Answer
E. coli Nissle 1917 is a probiotic strain that produces microcins and colicins, antimicrobial peptides that inhibit pathogenic bacteria in the gut. This strain enhances intestinal barrier function and modulates immune responses through toll-like receptor activation.
CategoryProbiotic & Fiber
GroupProbiotic Strain
Evidence LevelStrong
Primary KeywordE. coli Nissle 1917 benefits
Synergy Pairings3
Escherichia coli Nissle 1917 (Mutaflor) — botanical close-up
Health Benefits
Supports gut health by inhibiting pathogenic bacteria, promoting a balanced microbiome. This can lead to improved digestive function and reduced bloating. - Enhances immune response by stimulating the production of immunoglobulins, which helps protect against infections. - Reduces symptoms of IBS by modulating gut motility, providing relief from abdominal pain and discomfort. - Supports mental health by interacting with the gut-brain axis, potentially alleviating symptoms of anxiety and depression. - Promotes skin health by reducing systemic inflammation, leading to clearer, healthier skin. - Aids in nutrient absorption by maintaining a healthy gut lining, ensuring efficient uptake of vitamins and minerals. - Supports urinary tract health by preventing the colonization of harmful bacteria, reducing the risk of infections.
Origin & History
Natural habitat
Escherichia coli Nissle 1917 is a non-pathogenic strain of E. coli isolated in 1917. It is produced through fermentation and used in probiotic supplements for gastrointestinal health.
“Discovered during World War I, Escherichia coli Nissle 1917 has been used in Europe for decades to manage gastrointestinal disorders.”Traditional Medicine
Scientific Research
Clinical studies, including RCTs, have shown that Escherichia coli Nissle 1917 is effective in maintaining remission in ulcerative colitis and improving gut health.
Preparation & Dosage
Traditional preparation
The recommended dosage is typically one capsule per day. Consult a healthcare provider before use.
Nutritional Profile
How It Works
Mechanism of Action
E. coli Nissle 1917 produces microcins H47 and M, along with colicins Ia and Ib, which target pathogenic bacteria by disrupting their cell membranes. The strain activates toll-like receptors 2 and 4 on intestinal epithelial cells, triggering NF-κB signaling pathways that enhance antimicrobial peptide production. It also stimulates secretory IgA production and strengthens tight junctions through upregulation of claudin and occludin proteins.
Clinical Evidence
Clinical trials involving 200-300 participants show E. coli Nissle 1917 reduces IBS symptom severity by 40-60% compared to placebo over 6-12 weeks. Studies demonstrate 65-85% remission rates in ulcerative colitis maintenance therapy, comparable to mesalazine. Randomized controlled trials indicate significant reductions in pathogenic bacteria counts and improved intestinal permeability markers. Evidence quality is moderate to high for digestive conditions but limited for immune benefits.
Safety & Interactions
E. coli Nissle 1917 is generally well-tolerated with mild side effects including temporary bloating or gas in 5-15% of users during initial weeks. It may interact with immunosuppressive medications by potentially reducing their effectiveness through immune stimulation. The strain is contraindicated in severely immunocompromised individuals and those with central venous catheters due to bacteremia risk. Safety during pregnancy and breastfeeding has not been established through clinical trials.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the typical dosage of E. coli Nissle 1917?
The standard dosage ranges from 2.5-25 billion CFU daily, typically taken as 1-2 capsules with meals. Most clinical studies use 2.5-10 billion CFU daily for maintenance therapy in digestive conditions.
How long does it take for E. coli Nissle 1917 to work?
Initial colonization occurs within 1-2 weeks, but therapeutic benefits typically emerge after 4-6 weeks of consistent use. Maximum benefits for IBS and digestive symptoms are usually observed after 8-12 weeks.
Can E. coli Nissle 1917 be taken with antibiotics?
It should be separated from antibiotic doses by at least 2-3 hours to prevent bacterial killing. Many practitioners recommend starting or resuming E. coli Nissle 1917 supplementation after completing antibiotic courses.
Is E. coli Nissle 1917 safe for children?
Clinical studies have demonstrated safety in children as young as 1 year old for specific digestive conditions. However, pediatric dosing should be supervised by healthcare providers and typically uses lower CFU counts than adult formulations.
What makes E. coli Nissle 1917 different from other probiotics?
Unlike typical Lactobacillus or Bifidobacterium strains, this E. coli strain produces specific antimicrobial compounds called microcins and colicins. It also has unique capacity for long-term gut colonization and direct pathogen inhibition through competitive mechanisms.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
